Affiliations 

  • 1 Faculty of Pharmacy, Centre for Quality Management of Medicines, Universiti Kebangsaan Malaysia, Wilayah Persekutuan Kuala Lumpur, Malaysia
  • 2 Faculty of Economics and Management, Center for Value Creation and Human Well-being Studies, Universiti Kebangsaan Malaysia, Bangi, Selangor, Malaysia
  • 3 College of Pharmacy, Qatar University, Doha, Qatar
PLoS One, 2026;21(1):e0322604.
PMID: 41529026 DOI: 10.1371/journal.pone.0322604

Abstract

Pooled and segmented procurement are common in public health, but changing needs may prompt method shifts. Understanding their impact on drug prices is crucial for informed policy decisions. This study aimed to evaluate the impact of procurement method changes from pooled to segmented (P → S) and from segmented to pooled (S → P) on drug prices within Malaysia's public health sector. A five-year retrospective analysis was conducted using data from eight therapeutic subgroups, covering 73 drugs and 151 comparative procurements. The product price index measured price changes between procurement groups, and differences in probabilities and price index were assessed using Pearson Chi-square and Mann-Whitney U tests. The significance level was p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.